GlassScriptPhysician profile
Hee Kong Fong
NPI 1952751042
$11,518.68
in general payments reported to CMS, 2019-2025
25 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $711 · 2020: $741 · 2021: $1,867 · 2022: $2,293 · 2023: $3,625 · 2024: $1,919 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,272 · Travel and Lodging: $2,595 · Education: $39.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,272.30 |
| Travel and Lodging | $2,595.44 |
| Education | $39.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,696.72 | 2021-2023 | Supera, Pressurewire, Jeti Peripheral Catheter |
| Boston Scientific Corporation | $2,050.95 | 2019-2025 | Opticross, General - Balloon Catheters, Synergy |
| Medtronic, INC. | $1,926.17 | 2022-2024 | Micra, Resolute Onyx, Penditure |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $856.96 | 2019-2022 | |
| Abiomed | $714.62 | 2023-2025 | Impella |
| Shockwave Medical, INC | $537.04 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $452.03 | 2020-2022 | |
| Biotronik INC. | $448.23 | 2020-2024 | Recross, Orsiro Mission |
| Janssen Pharmaceuticals, INC | $363.74 | 2019-2021 | |
| Cardiovascular Systems INC. | $268.20 | 2022 | |
| Teleflex LLC | $170.13 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $160.13 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.14 | 2021-2023 | Jardiance |
| Cook Medical LLC | $128.67 | 2019 | |
| Amgen INC. | $115.00 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $90.83 | 2021-2024 | (Ck4) Mcot |
| Impulse Dynamics (USA) INC. | $78.38 | 2024 | Optimizer |
| Asahi Intecc USA, INC. | $70.96 | 2023 | Asahi Ptca Guide Wire |
| Terumo Medical Corporation | $68.30 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.24 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $36.36 | 2021 | |
| Medtronic Vascular, INC. | $33.26 | 2019 | |
| Pfizer INC. | $32.03 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.65 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hee Kong Fong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.